Other researchers quantitatively analyzed the serum exosomal lncRNA of NSCLC patients and healthy controls, and indicated thatTBILA and AGAP2-AS1 have diagnostic efficiency for early NSCLC patients [52]. Here, AGAP2 is linked to non-small cell lung carcinoma.